These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 957762)

  • 21. Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
    Sullivan HE; Wehner RJ
    AANA J; 1983 Jun; 51(3):284-9. PubMed ID: 6613506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bretylium tosylate for ventricular fibrillation in a child.
    Mongkolsmai C; Dove JT; Kyrouac JT
    Clin Pediatr (Phila); 1984 Dec; 23(12):696-8. PubMed ID: 6499350
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of quinidine and bretylium on defibrillation energy requirements.
    Dorian P; Fain ES; Davy JM; Winkle RA
    Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations.
    Jenzer HR; Hagemeijer F
    Eur J Cardiol; 1976 Dec; 4(4):447-51. PubMed ID: 63370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overdrive pacing in quinidine syncope and other long QT-interval syndromes.
    DiSegni E; Klein HO; David D; Libhaber C; Kaplinsky E
    Arch Intern Med; 1980 Aug; 140(8):1036-40. PubMed ID: 7396607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug corner: bretylium tosylate (Bretylol).
    Crit Care Nurse; 1980; 1(1):68-9. PubMed ID: 6914232
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bretylium tosylate--induced stabilization of electrical systole duration in patients with acute myocardial infarction.
    Jouve R; Puddu PE; Torresani J
    Heart Lung; 1982; 11(5):399-405. PubMed ID: 6921188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
    Dłuzniewski M
    Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of quinidine syncope by cardiac pacing].
    Gussarasky J; Kristal N; Gueron M
    Harefuah; 1972 Apr; 82(8):354-6. PubMed ID: 5050684
    [No Abstract]   [Full Text] [Related]  

  • 32. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of ventricular dysrhythmias in the prehospital and emergency department setting.
    Mayer NM
    Am J Cardiol; 1984 Jul; 54(2):34A-36A. PubMed ID: 6464998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia.
    Bauernfeind RA; Hoff JV; Swiryn S; Palileo E; Strasberg B; Scagliotti D; Rosen KM
    Am Heart J; 1983 Jun; 105(6):973-80. PubMed ID: 6858846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quinidine-induced paroxysmal ventricular fibrillation].
    Bjerkelund C; Skåland K
    Nord Med; 1967 Jan; 77(3):76-81. PubMed ID: 6023836
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia.
    Anderson JL; Mason JW
    Am J Med; 1978 Apr; 64(4):715-8. PubMed ID: 646873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of quinidine syncope in twenty cases.
    Chen H; Zong P; Pu S
    Chin Med J (Engl); 1997 Apr; 110(4):315-9. PubMed ID: 9594237
    [No Abstract]   [Full Text] [Related]  

  • 38. Bretylium tosylate therapy for ventricular fibrillation after cardiopulmonary bypass.
    Santora AH; Finucane BT
    South Med J; 1983 Sep; 76(9):1197-8. PubMed ID: 6612407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bretylium tosylate and ventricular fibrillation.
    Nowak RM
    Am J Emerg Med; 1983 Jul; 1(1):110-2. PubMed ID: 6680600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.